Liuying Township, Taiwan Clinical Trials

A listing of Liuying Township, Taiwan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4870 clinical trials
featured
Urinary Tract Infection

The purpose of this clinical research study is to evaluate an investigational medication compared to an already approved medication for treatment of a urinary tract infection.

dysuria
acute cystitis
cystitis
nitrite
urinary tract infection (uti)
  • 0 views
  • 11 Feb, 2021
  • 1 location
featured
Behavioral Correlates of the Rett Microbiome

Behavioral Correlates of the Rett Microbiome: The symptoms of Rett syndrome (RTT) are not only neurological, but frequently include gut problems, difficulties with nutrition, and altered levels of gut bacteria and bacterial metabolites. Gut distress and alterations in gut bacteria have been linked to numerous disorders, including anxiety, depression, stress, …

  • 0 views
  • 16 Apr, 2021
featured
A Washington University research study is currently enrolling female participants (18 to 45 years of age) to better understand the gut virome.

The purpose of this research study is to better understand the gut virome (virome is a collection of viruses in one location) of women at reproductive age, 18 to 45 years old. 

  • 0 views
  • 21 May, 2021
  • 1 location
featured
Planning Your Life Around Heavy Periods?

Planning Your Life Around Heavy Periods?

pelvic pain
  • 1142 views
  • 23 Nov, 2020
  • 1 location
featured
GOG 0263: Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy.

GOG 0263: Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy.

lymphadenectomy
hysterectomy
  • 800 views
  • 07 Nov, 2020
  • 1 location
featured
A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCl in Postmenopausal Women with Metastatic, Estrogen Receptor Positive, HER2 Negative Breast Cancer

A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCl in Postmenopausal Women with Metastatic, Estrogen Receptor Positive, HER2 Negative Breast Cancer

HER2
breast cancer
estrogen receptor
erbb2
estrogen
  • 378 views
  • 23 Nov, 2020
  • 1 location
featured
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

breast cancer
doxorubicin
carboplatin
cyclophosphamide
invasive breast cancer
  • 66 views
  • 03 Dec, 2020
  • 1 location
featured
ALTernate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer NeoAdjuvant TrEatment (ALTERNATE) in Postmenopausal Women: A Phase III Study

ALTernate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer NeoAdjuvant TrEatment (ALTERNATE) in Postmenopausal Women: A Phase III Study

breast cancer
estrogen
estrogen receptor
  • 150 views
  • 23 Nov, 2020
  • 1 location
featured
Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer

Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer

breast cancer
magnetic resonance imaging of breast
  • 96 views
  • 23 Nov, 2020
  • 1 location
featured
PHASE III RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL EVALUATING THE USE OF ADJUVANT ENDOCRINE THERAPY +/- ONE YEAR OF EVEROLIMUS IN PATIENTS WITH HIGH-RISK, HORMONE RECEPTOR-POSITIVE AND HER2/NEU NEGATIVE BREAST CANCER.

PHASE III RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL EVALUATING THE USE OF ADJUVANT ENDOCRINE THERAPY +/- ONE YEAR OF EVEROLIMUS IN PATIENTS WITH HIGH-RISK, HORMONE RECEPTOR-POSITIVE AND HER2/NEU NEGATIVE BREAST CANCER.

HER2
breast cancer
hormone therapy
erbb2
endocrine therapy
  • 220 views
  • 24 Nov, 2020
  • 1 location